Pathway Capital Management’s Affirm AFRM Stock Holding History

Pathway Capital Management’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-72,883	Closed	-$1.55M	–	14
2023 Q3	$1.55M	Buy	+72,883	New	+$1.33M	3.69%	6

Other funds holding AFRM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pathway Capital Management's AFRM Position: Q4 2023 in Review

Pathway Capital Management sold out of Affirm (AFRM) in Q4 2023, closing a stake of 72,883 shares — an estimated $1.55M sold.

Pathway Capital Management first reported a position in AFRM in Q3 2023 and held it in 1 quarter. The position peaked at $1.55M in Q3 2023. 408 funds tracked by Wall St. Rank hold AFRM as of Q4 2023.

Pathway Capital Management reported no remaining Affirm position as of Q4 2023 after selling out during the quarter.
Pathway Capital Management sold 72,883 Affirm shares in Q4 2023, an estimated $1.55M.
Pathway Capital Management first reported a position in Affirm in Q3 2023 and held it in 1 quarter.
Pathway Capital Management's Affirm position peaked at $1.55M in Q3 2023.
408 funds tracked by Wall St. Rank held Affirm as of Q4 2023.

Based on Pathway Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.